Integrating Magnetic Imaging With Rich Phenotypes
Launched by TOBIAS MOELLER-BERTRAM · Sep 23, 2024
Trial Information
Current as of July 30, 2025
Completed
Keywords
ClinConnect Summary
Mind-body interventions including meditation, reconceptualization, and placebo have been shown to improve a broad range of physical and mental health outcomes in both healthy and patient populations. How and what humans think about their health has a significant and quantifiable impact.
Placebo effects, another mind-body technique that creates health improvements, have been shown to impact every major organ system. More recently, open-label placebos, placebos administered without concealment such that the subject is aware of the placebo, have been shown to be effective for a host of health...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Must be 21 years of age or older
- • 2. Must speak English
- • 3. Must be a registered attendee of the advanced week-long meditation retreat
- • 4. Must be in generally good health
- • 5. Must agree to provide blood and buccal samples before and after the retreat
- • 6. Must be willing to wear a Garmin device for the entire retreat
- • 7. Must agree to fMRI scans before and after the retreat
- • 8. Must agree to qEEG measurements before, during, and after the retreat
- • 9. Must complete the research consent in its entirety
- • 10. Must be willing to complete self-report surveys for physical and emotional well-being
- Exclusion Criteria:
- • 1. Younger than 21 years of age
- • 2. Non-English speaking
- • 3. Not a registered attendee of the advanced week-long meditation retreat
- • 4. Not willing to complete the research consent
- • 5. Has a serious health condition
- • 6. Not willing to provide blood or buccal samples
- • 7. Does not agree to fMRI scans
- • 8. Not willing to wear a Garmin watch
- • 9. Does not agree to qEEG measurements
- • 10. Not willing or able to complete all self-report surveys
About Tobias Moeller Bertram
Tobias Moeller-Bertram is a distinguished clinical trial sponsor with a focus on advancing innovative therapeutic solutions in the healthcare sector. With a robust background in clinical research and development, Mr. Moeller-Bertram leads initiatives that prioritize patient safety, scientific rigor, and regulatory compliance. His commitment to fostering collaboration among multidisciplinary teams ensures the efficient execution of trials, contributing to the discovery of novel treatments and enhancing the quality of care. Through strategic partnerships and a patient-centered approach, he aims to address unmet medical needs and drive progress in the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palm Desert, California, United States
Patients applied
Trial Officials
Tobias Moeller-Bertram, MD
Principal Investigator
VitaMed Research LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported